Fore Capital’s Elanco Animal Health ELAN Stock Holding History

Fore Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$224K	–	71
2020 Q1	$224K	Buy	+10,000	New	+$274K	0.17%	50

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Fore Capital's ELAN Position: Q2 2020 in Review

Fore Capital sold out of Elanco Animal Health (ELAN) in Q2 2020, closing a stake of 10,000 shares — an estimated $224K sold.

Fore Capital first reported a position in ELAN in Q1 2020 and held it in 1 quarter. The position peaked at $224K in Q1 2020. 371 funds tracked by Wall St. Rank hold ELAN as of Q2 2020.

Fore Capital reported no remaining Elanco Animal Health position as of Q2 2020 after selling out during the quarter.
Fore Capital sold 10,000 Elanco Animal Health shares in Q2 2020, an estimated $224K.
Fore Capital first reported a position in Elanco Animal Health in Q1 2020 and held it in 1 quarter.
Fore Capital's Elanco Animal Health position peaked at $224K in Q1 2020.
371 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2020.

Based on Fore Capital's 13F filing for Q2 2020, filed 13 Aug 2020.